Acromus 0.1% Eye Ointment
Prescription Required
Product introduction
Acromus 0.1% Eye Ointment is a medicine used to treat allergic eye disease. It works by suppressing the immune response in the eye. Inhibiting specific immune cells activity reduces inflammation and symptoms such as itching, redness, and irritation.
Acromus 0.1% Eye Ointment is used to prevent the body rejecting the organ that is transplanted
Acromus 0.1% Eye Ointment is used to prevent the body rejecting the organ that is transplanted
Uses of Acromus Eye Ointment
Benefits of Acromus Eye Ointment
In Treatment of Allergic eye disease
Acromus 0.1% Eye Ointment belongs to a group of medicines known as immunosuppressive agents. It helps relieve symptoms of allergic eye disease such as redness, swelling, itching, and watering of eyes. This medicine works by decreasing the production of certain chemicals that cause inflammation. This will make it easier for you to go about your daily activities. Use it as prescribed to get the most benefit. If you see no improvement even after 2 weeks, talk to your doctor.
Side effects of Acromus Eye Ointment
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Acromus
- Eye irritation
- Burning sensation
How to use Acromus Eye Ointment
This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the tube close to the eye without touching it. Gently squeeze the tube and place the medicine inside the lower eyelid.
How Acromus Eye Ointment works
Acromus 0.1% Eye Ointment is an immunomodulator. It works by suppressing the action of a protein (calcineurin). This decreases the production of inflammatory chemicals by certain immune cells (T lymphocytes). This relieves allergic eye symptoms.
Safety advice
Alcohol
No interaction found/established
Pregnancy
CONSULT YOUR DOCTOR
Acromus 0.1% Eye Ointment may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Acromus 0.1% Eye Ointment is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Acromus 0.1% Eye Ointment may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
No interaction found/established
Liver
No interaction found/established
What if you forget to take Acromus Eye Ointment?
If you miss a dose of Acromus 0.1% Eye Ointment, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- You have been prescribed Acromus 0.1% Eye Ointment to treat inflammation (redness and swelling) due to allergies of the eye.
- If you wear soft contact lenses, remove them before using Acromus 0.1% Eye Ointment and wait at least 15 minutes before putting your lenses back in.
- Do not touch the tip to any surface, or to your eye, to avoid contamination.
- It may cause minor burning, stinging, or irritation in the eye. Inform your doctor if this does not go away.
- Consult your doctor if your eye condition has not improved after two weeks of treatment or if it gets worse.
- Continuous long-term use of the ointment should be avoided.
Fact Box
Chemical Class
Macrolide Lactams
Habit Forming
No
Therapeutic Class
OPHTHAL
Action Class
Immunosuppressant- Calcineurin inhibitors
Patient concerns
FAQs
Does Acromus 0.1% Eye Ointment have an abuse potential?
No, Acromus 0.1% Eye Ointment does not have abuse potential and thus, is not a controlled substance. Controlled substances have potential for abuse so they need permission from authorities and doctors for use.
What is Acromus 0.1% Eye Ointment? What is it used for?
Acromus 0.1% Eye Ointment belongs to a class of medicines known as immunosuppressant macrolides. It helps to relieve the symptoms of allergic eye disease such as pain, inflammation, redness and itching. Acromus 0.1% Eye Ointment alters the abnormal immune response, relieves the inflammation and itching and also helps in preventing frequent flare-ups.
What are the side effects of Acromus 0.1% Eye Ointment?
The most common side effects of Acromus 0.1% Eye Ointment include eye irritation and burning sensation. However, these are usually not bothersome and resolve on their own. If any of these side effects worry you or persist for a longer duration, please consult your doctor.
How does Acromus 0.1% Eye Ointment act?
Acromus 0.1% Eye Ointment belongs to a class of medicines known as immunosuppressant macrolides. It works by suppressing the action of a protein (calcineurin) which decreases the production of inflammatory chemicals by certain immune cells (T lymphocytes). This relieves the allergic eye symptoms such as pain, redness, swelling and itching.
How to use Acromus 0.1% Eye Ointment?
Remember to wash your hands before and after instilling Acromus 0.1% Eye Ointment. Try not to touch your eye with the dropper or the tip of the ointment tube. Try to use it at about the same time each day. Use the prescribed number of drops or the right amount of ointment. Do not use more medicine or use more often than directed. Do not stop using Acromus 0.1% Eye Ointment unless directed by your doctor and try not to miss any doses.
What other precautions should I take while using Acromus 0.1% Eye Ointment?
If you wear soft contact lenses, remove them before using Acromus 0.1% Eye Ointment. Wait for at least 15 minutes before putting your lenses back in. Do not touch the tip to any surface or your eye, to avoid contamination.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1822.
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 972.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1305-309.
- Tacrolimus monohydrate. Camberley, Surrey: Sandoz Limited; 2010 [revised 27 Mar. 2017]. [Accessed 23 Jan. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 06 Apr. 2019] (online) Available from:
- Erdinest N, Ben-Eli H, Solomon A. Topical tacrolimus for allergic eye diseases. Curr Opin Allergy Clin Immunol. 2019;19(5):535-543. [Accessed 07 Aug. 2023]. (online) Available from:
Marketer details
Name: Pharmatak Opthalmics Pvt Ltd
Address: 50-52, The Discovery, Dattapada Road, Borivali (E), Mumbai – 400 066, Maharashtra
Country of origin: India
Lab tests offered by us
Related/Popular tests
17 people viewed this recentlyMRP
₹200
Inclusive of all taxes
5.0 gm in 1 tube
SOLD OUT
Notify me